Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM P/E Multiple | -7.8x - -8.6x | -8.2x |
| Selected Fwd P/E Multiple | 110.3x - 121.9x | 116.1x |
| Fair Value | $4.58 - $5.07 | $4.83 |
| Upside | -21.5% - -13.2% | -17.4% |
| Benchmarks | - | Full Ticker |
| Ingevity Corporation | - | NYSE:NGVT |
| LSB Industries, Inc. | - | NYSE:LXU |
| Ginkgo Bioworks Holdings, Inc. | - | NYSE:DNA |
| Itafos Inc. | - | OTCPK:MBCF |
| C-Bond Systems, Inc. | - | OTCPK:CBNT |
| ASP Isotopes Inc. | - | NasdaqCM:ASPI |
| - | - | - |
| Select Price / LTM EPS Ratio | ||||||||
| Benchmark Companies | ||||||||
| NGVT | LXU | DNA | MBCF | CBNT | ASPI | |||
| NYSE:NGVT | NYSE:LXU | NYSE:DNA | OTCPK:MBCF | OTCPK:CBNT | NasdaqCM:ASPI | |||
| Historical Net Income Growth | ||||||||
| 5Y CAGR | NM- | NM- | NM- | NM- | NM- | NM- | ||
| 3Y CAGR | NM- | NM- | NM- | 19.8% | NM- | NM- | ||
| Latest Twelve Months | -7868.5% | -169.3% | 38.7% | 2173.8% | -244.1% | -115.6% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 4.0% | 2.1% | -370.4% | -1.1% | -470.9% | -1590.5% | ||
| Prior Fiscal Year | -0.3% | 4.7% | -355.1% | 0.8% | -231.9% | -3761.0% | ||
| Latest Fiscal Year | -30.6% | -3.7% | -240.9% | 17.9% | 74.0% | -847.3% | ||
| Latest Twelve Months | -30.6% | -3.7% | -240.9% | 17.9% | -70.3% | -847.3% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 6.5x | 10.3x | -0.7x | 2.2x | -2.8x | -15.5x | ||
| Price / LTM Sales | 0.8x | 0.7x | 1.9x | 0.6x | 0.1x | 101.6x | ||
| LTM P/E Ratio | -2.7x | -19.0x | -0.8x | 3.5x | -0.1x | -12.0x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/E Ratio | -19.0x | -0.8x | 3.5x | |||||
| Historical LTM P/E Ratio | -12.0x | -9.2x | -6.5x | |||||
| Selected P/E Multiple | -7.8x | -8.2x | -8.6x | |||||
| (x) LTM Net Income | (35) | (35) | (35) | |||||
| (=) Equity Value | 274 | 288 | 303 | |||||
| (/) Shares Outstanding | 72.1 | 72.1 | 72.1 | |||||
| Implied Value Range | 3.80 | 4.00 | 4.20 | |||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 3.80 | 4.00 | 4.20 | 5.84 | ||||
| Upside / (Downside) | -34.9% | -31.5% | -28.1% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | NGVT | LXU | DNA | MBCF | CBNT | ASPI | |
| Value of Common Equity | 1,151 | 369 | 427 | 300 | 0 | 421 | |
| (/) Shares Outstanding | 36.4 | 71.8 | 54.4 | 192.5 | 596.3 | 72.1 | |
| Implied Stock Price | 31.58 | 5.13 | 7.85 | 1.56 | 0.00 | 5.84 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 31.58 | 5.13 | 7.85 | 1.56 | 0.00 | 5.84 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |